Compare Enveric Biosciences Inc (ENVB) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs First Trust Cloud Computing ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while First Trust Cloud Computing ETF trades at $161.15. The key difference: First Trust Cloud Computing ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SKYY | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | — |
52-Week High | $17.40 | $161.09 |
52-Week Low | $1.27 | $104.16 |
Enterprise Value | $1.30M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.
Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.
SKYY, trading at $156.17, gained 3.71% today, reflecting strong bullish momentum from moving averages and positive sentiment around cloud computing and AI trends. The ETF's technical indicators show overbought conditions with RSI levels above 76, while support is firm near $155. Recent news highlights SKYY's diversified exposure to cloud infrastructure and AI, benefiting from secular growth in digital transformation.
Outlook remains positive due to AI adoption and cloud migration tailwinds, but risks include overvaluation concerns and competitive pressures. Investors should weigh the strong technical trend against high RSI readings and monitor earnings growth for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
